Global non-alcoholic steatohepatitis market to reach over $1.5 billion through 2020
This market research report includes a detailed segmentation of the global non-alcoholic steatohepatitis market by dosage form (solid and liquid) and by route of administration (oral and parenteral). It also outlines the market shares for key regions like the Americas, APAC, and Europe. The leading vendors analyzed in this report are AstraZeneca, Arena Pharmaceuticals, GlaxoSmithKline,…
